Short Interest in Relief Therapeutics Holding SA (OTCMKTS:RLFTF) Rises By 5,300.0%

Relief Therapeutics Holding SA (OTCMKTS:RLFTF) was the recipient of a large increase in short interest in the month of October. As of October 15th, there was short interest totaling 5,400 shares, an increase of 5,300.0% from the September 30th total of 100 shares. Based on an average daily volume of 8,800 shares, the short-interest ratio is presently 0.6 days. Based on an average daily volume of 8,800 shares, the short-interest ratio is presently 0.6 days.

Relief Therapeutics Trading Up 5.2%

RLFTF opened at $3.79 on Tuesday. The firm has a fifty day moving average price of $3.65 and a 200 day moving average price of $3.16. Relief Therapeutics has a 1 year low of $2.25 and a 1 year high of $7.66.

Relief Therapeutics Company Profile

Relief Therapeutics Holding AG, a biopharmaceutical company, focuses on identification, development, and commercialization of novel, patent protected products for the treatment of metabolic, dermatological, and pulmonary rare diseases in Switzerland, Europe, North America, and internationally. The company offers SETOFILM/ONDISSOLVE for radiotherapy induced nausea and vomiting, and chemotherapy induced nausea and vomiting, as well as postoperative induced nausea and vomiting.